Abstract:The trial was conducted to study on the effects of different type of sodium butyrate on serum bio-chemical indices, antioxidant and anti-inflammatory function of broilers challenged with lipopolysaccharide ( LPS) . Feeding trial: a total of 1 000 one-day-old Lingnan yellow broilers were randomly allocated into 5 groups with 4 replicates in each group and 50 broilers per replicate. Broilers in control group were fed a basal diet, the others in experimental groups were fed the basal diets supplemented with 500 mg/kg powder sodium butyrate ( NaB) , and 250, 500 and 750 mg/kg coated sodium butyrate ( CNaB) , respectively. The LPS in-jection experiment was conducted followed a 50-day feeding trial, 72 fifty-day-old female broilers were select-ed randomly from control, NaB and 250 mg/kg CNaB group with the best growth performance, with 6 broilers per replicate. And they were allotted into a 2×3 factorial arrangement with challenge status (saline or LPS ex-posure) and feed diet (0, 500 mg/kg NaB or 250 mg/kg CNaB) as main factor for endotoxin exposure test. Half of broilers in each group were injected intraperitoneally with E.coli LPS (0.5 mg/kg body weight)at 53, 56 and 59 d of age, the remaining broilers were injected intraperitoneally with the same amount of saline as the LPS injected group. The trial lasted for 10 days. The results showed as follows: 1) compared with the saline injected group, the content of glucose and riglyceride in serum was significantly decreased in LPS injected group (P<0.05), but the serum uric acid content as significantly increased (P<0.05). The serum glucose content of NaB and CNaB groups injected with LPS was significantly higher than that of control group ( P<0.05) . 2) Compared with the saline injected group, the activity of superoxide dismutase ( SOD) and glutathi-one peroxidase ( GSH-Px) in serum and liver was significantly decreased in LPS injected group ( P<0. 05 or P<0.01) , the serum catalase ( CAT) activity was significantly decreased ( P<0.05) . The activity of SOD and CAT in serum and liver of NaB and CNaB groups injected with LPS was higher than that of control group ( P>0.05), but the malonaldehyde content was lower than that of control group (P>0.05). There were a signifi-cant interaction between dietary sodium butyrate and LPS injected on liver GSH-Px activity ( P<0.05) , and the two forms of sodium butyrate exerted an equal effect on antioxidant enzyme activity. 3) Compared with the sa-line injected group, the content of ceruloplasmin and interleukin-6 in serum at the age of 53 and 59 days was significantly increased in LPS injected group ( P<0.05) . The serum ceruloplasmin content at the age of 53 days of NaB and CNaB groups injected with LPS was significantly lower than that of control group (P<0.05). In conclusion, sodium butyrate can improve the nutrient metabolism, maintain antioxidant function and promote anti-inflammation function, the effects on anti-stress of 500 mg/kg NaB are equal to those of 250 mg/kg CNaB which contains 75 mg/kg effective substance.

Sodium butyrate protects against oxidative stress in HepG2 cells through modulating Nrf2 pathway and mitochondrial function

Sodium butyrate protects against high-fat diet-induced oxidative stress in rat liver by promoting expression of nuclear factor E2-related factor 2

Sodium Butyrate Ameliorates Oxidative Stress-Induced Intestinal Epithelium Barrier Injury and Mitochondrial Damage through AMPK-Mitophagy Pathway

Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c‐myc/hexokinase 2 pathway

Sodium Butyrate Protects Against Oxidative Stress in Human Nucleus Pulposus Cells Via Elevating PPARγ-regulated Klotho Expression.

Sodium Butyrate Ameliorates Deoxynivalenol-Induced Oxidative Stress and Inflammation in the Porcine Liver Via NR4A2-Mediated Histone Acetylation.

Sodium Butyrate Protects Against Rotavirus-Induced Intestinal Epithelial Barrier Damage by Activating AMPK-Nrf2 Signaling Pathway in IPEC-J2 Cells

Sodium Butyrate Attenuates AGEs-Induced Oxidative Stress and Inflammation by Inhibiting Autophagy and Affecting Cellular Metabolism in THP-1 Cells

Regulation of hepatic genes related to lipid metabolism and antioxidant enzymes by sodium butyrate supplementation

Neuroprotective Effect of Sodium Butyrate against Cerebral Ischemia/Reperfusion Injury in Mice

Sodium Butyrate Inhibits Migration and Induces AMPK-mTOR Pathway-Dependent Autophagy and ROS-mediated Apoptosis Via the Mir-139-5p/bmi-1 Axis in Human Bladder Cancer Cells.

Dual Effects of Sodium Butyrate on Hepatocellular Carcinoma Cells

Sodium butyrate alleviates intestinal injury and microbial flora disturbance induced by lipopolysaccharides in rats

Sodium butyrate attenuates angiotensin II‐induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6‐dependent mechanism

Effects of Different Type of Sodium Butyrate on Serum Biochemical Indices, Antioxidant and Anti-Inflammatory Function of Broilers Challenged with Lipopolysaccharide

Sodium Butyrate Induces Mitophagy and Apoptosis of Bovine Skeletal Muscle Satellite Cells through the mTOR Signaling Pathway

Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene

Sodium Butyrate Attenuates High-Fat Diet-Induced Steatohepatitis in Mice by Improving Gut Microbiota and Gastrointestinal Barrier.

Protective effect of sodium butyrate on intestinal barrier damage and uric acid reduction in hyperuricemia mice

Suppression of HDAC2 by Sodium Butyrate Alleviates Apoptosis of Kidney Cells in Db/db Mice and HG-induced NRK-52E Cells

Sodium butyrate protect bone mass in lipopolysaccharide-treated rats by reducing oxidative stress and inflammatory